ERCC6 and neutropenia: In subgroup of patients receiving GP regimen (Fig. 1E), rs4253212 (χ2 test P = 4.92 × 10−5; OR = 3.31, 95%CI:1.26–8.72, P = 0.015) in ERCC6 was significantly associated with neutropenia.